Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein ...

Radiolabeled biologics whether amino acids, cells, antibodies, proteins, viruses or synthetic ligands have potential for functional imaging and therapy. To ...

As AI continues to evolve, its integration with medical imaging may revolutionize how doctors understand and treat brain conditions, making surgeries safer and more effective for patients worldwide.

A study reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta -- a hallmark of Alzheimer's disease. The findings suggest that vascular ...

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.

At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Genes play a role in whether someone gets Alzheimer's, but new research from Northeastern University psychology and ...